knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 15:22:28 - browse：13521

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Abbott's new stent may help patients with peripheral artery disease

focus

hotspot

WSS

What we’ve learned from the Aduhelm mess

The dental labor crisis is a moment of opportunity

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

For Medicare Advantage, Democrats want stronger protections around AI

Supreme Court to hear if Covid misinformation is protected speech

knowledge

knowledge

focus

In Memoriam: Notable people who died in 2023

Fertility clinic egg and embryo storage is a disaster

State Dept. review finds Biden bears some blame for Afghanistan failures

HHS suspends federal funding for EcoHealth Alliance

The high cost of giving birth even with insurance

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Psychedelics group wrestles with new pharma identity

The Readout: Gilead, Bernie Sanders, and other pharma news

Continuity nursing helped my family in our darkest PICU moments

As H5N1 spreads in cows, experts warn against drinking raw milk

hotspot

To avoid data mishandling cases, universities eye AI and other tools

Medicare threatens to cut off funding for HCA's Mission hospital

Biogen Alzheimer’s drug launch off to slow start

Fertility clinic egg and embryo storage is a disaster

Key House Republican on health care plans exit from Congress

HHS suspends federal funding for EcoHealth Alliance

focus

hotspot

hotspot

Wikipedia